Cue Biopharma

-$2.61 (-24.62%) Today
+$0.29 (+3.63%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease.

CEO
Daniel R. Passeri
Employees
50
Headquarters
Cambridge, Massachusetts
Founded
2014

CUE Key Statistics

Market cap
253.77M
Price-Earnings ratio
—
Dividend yield
—
Average volume
565.37K
High today
$9.99
Low today
$7.19
Open price
$9.99
Volume
1.65M
52 Week high
$18.42
52 Week low
$7.19

CUE News

Benzinga14h

Cue Pharma Posts Two Responses From CUE-101 Combo In Head & Neck Cancer

Early data from a trial evaluating Cue Biopharma Inc's (NASDAQ: CUE) CUE-101 combined with Merck & Co Inc's (NYSE: MRK) Keytruda (pembrolizumab) demonstrated th

CUE Earnings

-$0.42
-$0.28
-$0.14
-$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure